A randomized, double-blind, double-dummy, placebo-controlled trial to determine the relative effect of PM101 I.V. versus placebo on hemodynamics in healthy adult volunteers
Phase of Trial: Phase I
Latest Information Update: 15 Oct 2009
At a glance
- Drugs Amiodarone (Primary)
- Indications Arrhythmias; Heart failure
- Focus Adverse reactions
- Sponsors Prism Pharmaceuticals
- 15 Oct 2009 Results have been published in the American Journal of Cardiology.
- 16 Jan 2008 Status change from recruiting to completed.
- 11 Aug 2007 New trial record.